Abstract

The impact of rheumatic diseases on quality of life is impressive. Functional impairment, productivity loss, and healthcare costs due to rheumatic disease belong to the top. The introduction of biologicals...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Physician gender is associated with the quality of type 2 diabetes care
M Böhm ... K P Bestehorn
Journal of Internal Medicine | VOL. 264
M Böhm, et. al.M Böhm ... K P Bestehorn
10 Sep 2008
Geographic Variation in the Quality and Cost of Care for Patients with Rheumatoid Arthritis.
Arijit Ganguli ... Yuri Sanchez Gonzalez
Journal of managed care & specialty pharmacy | VOL. 22
Arijit Ganguli, et. al.Arijit Ganguli ... Yuri Sanchez Gonzalez
01 Dec 2016
Quality of antenatal care and associated factors among pregnant women attending government hospitals in Sidama Region, Southern Ethiopia.
Nigussie Yohanes Yote ... Amelo Bolka Gujo
SAGE open medicine | VOL. 9
Nigussie Yohanes Yote, et. al.Nigussie Yohanes Yote ... Amelo Bolka Gujo
01 Jan 2020
Pattern and perception of wellbeing, quality of work life and quality of care of health professionals in Southwest Nigeria
Ayomikun F Ayodeji ... Olufemi O Oyewole
BMC Health Services Research | VOL. 22
Ayomikun F Ayodeji, et. al.Ayomikun F Ayodeji ... Olufemi O Oyewole
22 Nov 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers